top of page
top_bg_publications.png

연구 성과

bg_publications.png
​연구 성과

29

Gut Microbiota Defines Functional Direction of Colonic Regulatory T Cells with Unique TCR Repertoires

J Immunol. 2024 Sep 15;213(6):886-897

Byun S, Lee J, Choi YH, Ko H, Lee C, Park JC, Kim SW, Lee H, Sharma A, Kim KS, Rudra D, Kim JK, Im SH.

28

A dietary commensal microbe enhances antitumor immunity by activating tumor macrophages to sequester iron

Nat Immunol. 2024 May;25(5):790-801

Sharma G, Sharma A, Kim I, Cha DG, Kim S, Park ES, Noh JG, Lee J, Ku JH, Choi YH, Kong J, Lee H, Ko H, Lee J, Notaro A, Hong SH, Rhee JH, Kim SG, De Castro C, Molinaro A, Shin K, Kim S, Kim JK, Rudra D, Im SH.

27

Cell-cell communication network-based interpretable machine learning predicts cancer patient response to immune checkpoint inhibitors

Sci Adv. 2024 Feb 2;10(5):eadj0785

Lee J, Kim D, Kong J, Ha D, Kim I, Park M, Lee K, Im SH, Kim S.

26

Exploring probiotic effector molecules and their mode of action in gut-immune interactions

FEMS Microbiol Rev. 2023 Jul 5;47(4):fuad046

Lee CG, Cha KH, Kim GC, Im SH, Kwon HK.

25

Drug approval prediction based on the discrepancy in gene perturbation effects between cells and humans

EBioMedicine. 2023 Aug;94:104705

Park M, Kim D, Kim I, Im SH, Kim S.

24

Marchf6 E3 ubiquitin ligase critically regulates endoplasmic reticulum stress, ferroptosis, and metabolic homeostasis in POMC neurons

Cell Rep. 2023 Jul 25;42(7):112746

Mun SH, Lee CS, Kim HJ, Kim J, Lee H, Yang J, Im SH, Kim JH, Seong JK, Hwang CS.

23

Forkhead box protein D2 suppresses colorectal cancer by reprogramming enhancer interactions

Nucleic Acids Res. 2023 Jul 7;51(12):6143-6155

Kim HM, Kang B, Park S, Park H, Kim CJ, Lee H, Yoo M, Kweon MN, Im SH, Kim TI, Roh TY.

22

The transcription factor Mef2d regulates B:T synapse-dependent GC-T(FH) differentiation and IL-21-mediated humoral immunity

Sci Immunol. 2023 Mar 31;8(81):eadf2248

Kim YJ, Oh J, Jung S, Kim CJ, Choi J, Jeon YK, Kim HJ, Kim JW, Suh CH, Lee Y, Im SH, Crotty S, Choi YS.

이뮤노바이옴(주)

대표전화 054-279-4429     |

이메일 contact@immunobiome.co.kr     |

사업자번호 610-87-01336

경상북도 포항시 남구 지곡로 47 바이오오픈이노베이션센터 2101호

  • 링크드 인
bottom of page